Camila Marques
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camila Marques has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Alexandrina Sartori
Department of Chemical and Biological Sciences, Institute of Biosciences, São Paulo State University (UNESP), Botucatu 18618-689, Brazil
1 shared publication - Fernanda Chiuso-Minicucci
Department of Microbiology and Immunology, Biosciences Institute, São Paulo State University (UNESP), 18618-000 Botucatu, SP, Brazil
1 shared publication - Larissa Camargo da Rosa
Department of Structural and Functional Biology, Institute of Biology, University of Campinas, UNICAMP, Campinas, SP, Brazil
1 shared publication - Larissa Lumi Watanabe Ishikawa
Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA
1 shared publication - Maria de Lourdes Ribeiro de Souza da Cunha
Department of Tropical Diseases, Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-689, SP, Brazil
1 shared publication - Maura Rosane Valerio Ikoma‐Colturato
43Flow Cytometry Laboratory, Hospital Amaral Carvalho, Jaú São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 9 January 2014
- Published by Springer Nature in BMC Neuroscience
- Vol. 15 (1) , 8
Previous infection with Staphylococcus aureusstrains attenuated experimental encephalomyelitis
Background: Bacterial superantigens are potent T cell activators that can activate T cells with specificity for antigens of the central nervous system (CNS). In this study, we compared the effect of twoS. aureusstrains on experimental autoimmune encephalomyelitis (EAE) development. C57BL/6 female mice were infected withS. aureusATCC 51650, which produces toxic shock syndrome toxin 1 (TSST-1+) orS. aureusATCC 43300, which does not produce toxins (TOX-). Three days later, the animals were subjected to EAE induction by immunization with myelin oligodendrocyte glycoprotein (MOG). The weight variation, disease incidence and clinical score were recorded daily. Cytokines and Foxp3+ regulatory T cells in the brain were evaluated during the acute disease phase. Cytokines and Foxp3+ regulatory T cells in the spleen and histopathological analysis of the CNS were assessed during the chronic stage.Results: Previous infection with both strains similarly decreased the clinical score; however, only the TSST-1+ strain clearly diminished inflammation in the CNS. The infections also modulated cytokine production in the spleen and CNS. Reduced production of IL-5 and IL-10 was detected in MOG-stimulated spleen cultures in the TOX- and TSST-1+ infected groups, respectively. InS. aureusstimulated cultures, there was an increased production of IFN-γ and IL-10 in both infected groups and an increased level of IL-5 in the TSST-1+ group. CNS infiltrating cell cultures from previously infected mice produced less IL-17 in response to MOG and more IFN-γ in response toS. aureusstimulation.Conclusions: These results indicated that both strains attenuated clinical EAE manifestations, but only TSST-1 clearly decreased CNS inflammation.
- 9 January 2014
- Published by Springer Nature in BMC Neuroscience
- Vol. 15 (1) , 8
Open AccessPrevious infection with Staphylococcus aureusstrains attenuated experimental encephalomyelitis
Background: Bacterial superantigens are potent T cell activators that can activate T cells with specificity for antigens of the central nervous system (CNS). In this study, we compared the effect of twoS. aureusstrains on experimental autoimmune encephalomyelitis (EAE) development. C57BL/6 female mice were infected withS. aureusATCC 51650, which produces toxic shock syndrome toxin 1 (TSST-1+) orS. aureusATCC 43300, which does not produce toxins (TOX-). Three days later, the animals were subjected to EAE induction by immunization with myelin oligodendrocyte glycoprotein (MOG). The weight variation, disease incidence and clinical score were recorded daily. Cytokines and Foxp3+ regulatory T cells in the brain were evaluated during the acute disease phase. Cytokines and Foxp3+ regulatory T cells in the spleen and histopathological analysis of the CNS were assessed during the chronic stage.Results: Previous infection with both strains similarly decreased the clinical score; however, only the TSST-1+ strain clearly diminished inflammation in the CNS. The infections also modulated cytokine production in the spleen and CNS. Reduced production of IL-5 and IL-10 was detected in MOG-stimulated spleen cultures in the TOX- and TSST-1+ infected groups, respectively. InS. aureusstimulated cultures, there was an increased production of IFN-γ and IL-10 in both infected groups and an increased level of IL-5 in the TSST-1+ group. CNS infiltrating cell cultures from previously infected mice produced less IL-17 in response to MOG and more IFN-γ in response toS. aureusstimulation.Conclusions: These results indicated that both strains attenuated clinical EAE manifestations, but only TSST-1 clearly decreased CNS inflammation.